Acceleration of MRP-associated efflux of rhodamine 123 by genistein and related compounds
1996

Effects of Genistein on Drug Transport in Cancer Cells

publication Evidence: moderate

Author Information

Author(s): CHM Versantvoort, T Rhodes, PR Twentyman

Primary Institution: Medical Research Council, Clinical Oncology and Radiotherapeutics Unit

Hypothesis

Genistein and related compounds affect the transport of rhodamine 123 and daunorubicin in MRP-overexpressing lung cancer cell lines.

Conclusion

Genistein increases daunorubicin accumulation while decreasing rhodamine 123 accumulation in MRP-overexpressing cancer cells.

Supporting Evidence

  • Genistein increased daunorubicin accumulation in MRP-overexpressing cell lines.
  • Genistein decreased rhodamine 123 accumulation in resistant cancer cells.
  • Flavonoids showed different effects on drug transport in MRP-overexpressing cells.

Takeaway

This study found that a natural compound called genistein can help some cancer cells take in more of a drug called daunorubicin, but it makes them lose a different dye called rhodamine 123.

Methodology

The study used human lung cancer cell lines to measure the effects of genistein and other flavonoids on drug accumulation and efflux.

Limitations

The study primarily focused on specific cell lines and may not generalize to all cancer types.

Participant Demographics

Human lung cancer cell lines were used, including MRP-overexpressing variants.

Statistical Information

P-Value

p<0.02

Statistical Significance

p<0.02

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication